S069-4293 Screening compound: 3,3-dimethyl-5-({3-[5-(3-pyridyl)-1,2,4-oxadiazol-3-yl]-1-pyrrolidinyl}sulfonyl)-1,3-dihydro-2H-indol-2-one

S069-4293 Screening compound: 3,3-dimethyl-5-({3-[5-(3-pyridyl)-1,2,4-oxadiazol-3-yl]-1-pyrrolidinyl}sulfonyl)-1,3-dihydro-2H-indol-2-one
S069-4293 Screening compound: 3,3-dimethyl-5-({3-[5-(3-pyridyl)-1,2,4-oxadiazol-3-yl]-1-pyrrolidinyl}sulfonyl)-1,3-dihydro-2H-indol-2-one alternative view

Chemical Structure Depiction of ChemDiv screening compound S069-4293
3,3-dimethyl-5-({3-[5-(3-pyridyl)-1,2,4-oxadiazol-3-yl]-1-pyrrolidinyl}sulfonyl)-1,3-dihydro-2H-indol-2-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S069-4293

Molecular Formula

C21H21N5O4S (C21 H21 N5 O4 S)

Compound Name

3,3-dimethyl-5-({3-[5-(3-pyridyl)-1,2,4-oxadiazol-3-yl]-1-pyrrolidinyl}sulfonyl)-1,3-dihydro-2H-indol-2-one

IUPAC name

n/a

SMILES

CC(C)(c(cc(cc1)S(N(CC2)CC2c2noc(-c3cnccc3)n2)(=O)=O)c1N1)C1=O

InChI

InChI=1S/C21H21N5O4S/c1-21(2)16-10-15(5-6-17(16)23-20(21)27)31(28,29)26-9-7-14(12-26)18-24-19(30-25-18)13-4-3-8-22-11-13/h3-6,8,10-11,14H,7,9,12H2,1-2H3,(H,23,27)/t14-/m1/s1

InChI Key

SEDGYKNBKXDWEI-CQSZACIVSA-N

MDL Number (MFCD)

MFCD29007607

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

439.5

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.501

Distribution Coefficient, logD

2.407

Water Solubility, LogSw

-2.89

Polar Surface Area

98.416

Acid Dissociation Constant (pKa)

10.86

Base Dissociation Constant (pKb)

6.78

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

33.30

S069-4293 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

Bcl2-PPI Inhibitors Library (12246 compounds)

Indole Derivatives (10091 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Anti-HIV1 Library (19540 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

MEF2-HDAC (class II) Modulators Library (5147 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Hemic and lymphatic
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Cancer
  • Musculoskeletal
  • Female
  • Hemic and lymphatic
  • Cardiovascular
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • Epigenetic
Structure:
  • Cyclic compounds
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with S069-4293 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S069-4293?
Check Price and Availability of S069-4293, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S069-4293 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S069-4293
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S069-4293
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S069-4293 available by request